Take your Annual Meeting experiencemobile with the new ASCP app. The most current meeting information is available at your fingertips. Available for your iPhone or Android.
Author Archives: ev1
Anatomical Venuses! Anthropomorphic Taxidermy! Books Bound in Human Skin! Announcing "The Morbid Anatomy Anthology"
Digital Pathology Debate Continues: Hope or Hype?
Courtesy of Dark Daily: During Pathology Informatics 2012, a record crowd gathered last week to explore how new technologies are reshaping both clinical laboratory informatics and anatomic pathology informatics. If there was clear consensus on any single point, it was...
Institute of Medicine Published Anticipated Study on AFIP Tissue Repository
The Institute of Medicine (IOM) has published its much anticipated study on the future use of the Department of Defense’s (DoD) biorepository (previously known as the AFIP Tissue Repository) which was created fromseveral decades of collecting tissue samples from military...
Are you Ready for Pathology Visions 2012?
ARE YOU READY FOR PATHOLOGY VISIONS 2012? Register for Pathology Visions 2012 Pathology Visions will give you the opportunity to learn about real-world, practical applications in the ever-evolving field of digital pathology. The Digital Pathology Association’s annual meeting will give...
PathXL Biobank Introductory Webinar
Wednesday 24th October 2012, 3:15pm GMT / 4:15pm CET What Is It? PathXL® Biobank is a highly configurable sample collection, tracking, storage, management and distribution platform that provides the flexibility required to build customised solutions across a range of biobank...
Care and Conservation of Early 19th Century Wax Anatomical Models
Source:
http://morbidanatomy.blogspot.com/2012/10/care-and-conservation-of-early-19th.html
Morbid Anatomy Library: One of the "7 Grossest Wonders of the USA," According to CNN
Thanks to good friend and genius writer Richard Faulk--author of the unfortunately named but no less wonderful Gross America--The Morbid Anatomy Library has just been awarded the dubious honor of being voted one of the top 7 "Grossest Wonders of the USA" on CNN.
You can read Mr. Faulk's entire list, and his entry on The Morbid Anatomy Library, by clicking here. You can find out more about the elegantly and eruditely written book--and even buy a copy of your own!--by clicking here.
To find out more about the library, click here; for those curious to see this "weird art and antique medicine cum gallery and lecture space [which] hosts occasional classes in anthropmorphic taxidermy," please stop by open hours this Sunday, 1-6. More on that here.
Source:
http://morbidanatomy.blogspot.com/2012/10/morbid-anatomy-library-one-of-7.html
Ars Moriendi (The Art of Dying), Loreto Prague, Through November 30th
ARS MORIENDI
Loreto Prague, Loretánské nám.7, 118 00 Praha 1 – Hrad?any
Exhibition extended until 30th November.
The aim of the exhibition is, above all, to introduce to the public the hitherto unknown space of the crypt for benefactors beneath the church of the Nativity of Our Lord. A fascinating discovery in the crypt revealed unique Baroque mural paintings depicting motifs of Death and Resurrection – allegories of Time, symbols of fragility and transience of human existence. These frescos of exceptional quality were created in 1664 by the means of the special technique of chiaroscuro – employing exclusively the shades of black and grey. The work of their author, perhaps a Capuchin order painter, was derived from the Flemish and Dutch prints and was commissioned by the then patroness of Loreto, Countess Elisabeth Apollonia of Kolowrat. The main scene depicting the Raising of Lazarus was based on the famous etching by Rembrandt, which later inspired numerous artists across the centuries, including Van Gogh – the Loreto fresco is remarkable because it is a very early reaction to Rembrandt’s work created while he was still alive...... Part of the presentation will be dedicated to other interesting exhibits associated with the burial practices in Loreto – for example the unknown ground plan of the Lobkowicz crypt of patrons beneath Santa Casa, design of Castrum Doloris created in 1698 for the burial of the Count Václav Ferdinand of Lobkowicz, collection of the Baroque funerary textiles or several reliquary crosses which were part of the Loreto treasure and had not yet been exhibited.
The exhibition will also introduce the customs related to burying in the Capuchin order crypts. Borrowed for this occasion from the Brno crypt were Baroque coffin lids with painted decoration, portraits and coats of arms of selected donors who sought their final resting place with the Capuchins. The perception of the order spirituality of Franciscan observance in the funerary sphere is broadened by the presentation of two Baroque Franciscan convent mortuaries.
It rarely happens that an entirely unknown monument in the centre of Prague is discovered. The Loreto exhibition offers an opportunity to get more closely acquainted with the impressive crypt space decorated with unique paintings and with the Baroque ARS MORIENDI – The Art of Dying – the inner grasp of the end of human existence as a gate to eternal life.
Source:
http://morbidanatomy.blogspot.com/2012/10/ars-moriendi-art-of-dying-loreto-prague.html
Pathology Visions 2012 to Offer Regulatory Update
At the Digital Pathology Associations (DPA) upcoming annual conference Pathology Visions, being held October 28-30, 2012 in Baltimore, MD, the College of American Pathologists (CAP) Pathology and Laboratory Quality Center will be featuring a special presentation to follow up from the Regulatory Panel featured at Pathology Visions 2011.
Indianapolis, IN (PRWEB) October 18, 2012
The DPA hosted a Regulatory Panel in 2011 titled Navigating Digital Pathologys Path to Patients that gave participants a new insight into the evolving regulatory process for digital pathology products. Now at Pathology Visions 2012, the DPA is yet again highlighting the movement towards validating whole slide images.
CAP Pathology and Laboratory Quality Centers presentation for Pathology Visions 2012 titled Recommendations for Validating Whole Slide Imaging for Diagnostic Purposes in Pathology will focus on answering the question: what needs to be done to validate a whole slide digital imaging system for diagnostic purposes before it is placed in clinical service? The panel making the presentation includes Dr. Liron Pantanowitz, MD, FCAP, Chair; Anil Parwani, MD, PhD, FCAP and Andrew Evans, MD,PhD, FCAP. These panelists conducted a systematic review of international literature and addressed intended use, preparation types, case numbers, equipment, personnel, and process to reach their final recommendations included in the presentation.
In addition to the Regulatory Update, there will be over 40 presenters featured at Pathology Visions 2012. These presentations give attendees the opportunity to earn 11 continuing medical education (CME) credits throughout the conference.
Registration for Pathology Visions is still open. Please click here to register now and visit our website for more information on the Regulatory Update, CME credit and a complete list of the presenters and their topics.
About the Digital Pathology Association
The Digital Pathology Association, located in Indianapolis, IN, was founded in 2009. Its mission is to facilitate education and awareness of digital pathology applications in healthcare and life sciences. Members are encouraged to share best practices and promote the use of technology among colleagues in order to demonstrate efficiencies, awareness, and its ultimate benefits to patient care. To learn more about the DPA and Pathology Visions, please visit our website.
Michael F. Ward, CAE Digital Pathology Association (DPA) 317.816.1630 101 Email Information
View original post here:
Pathology Visions 2012 to Offer Regulatory Update
Rapidly Expanding Australian Natural Healthcare Company Goes Global
Growing waistlines feed weight loss firm Rapid Nutrition's success
Brisbane, Queensland (PRWEB) October 18, 2012
Rapid Nutrition, whose flagship product Leisas Secret, a set of scientifically formulated weight loss and maintenance supplements, has already achieved considerable success both in Australia and overseas.
Rapid Nutritions listing will provide the necessary capital to support our international expansion plans, particularly into our target markets in the United States, India and neighboring Asian countries, Mr St Ledger says.
The company has already attracted the interest of large corporate investors as well as high net worth individuals in addition to being surrounded by a highly experienced advisory board.
Whilst it is always nice to successfully attract investment into the company, it also provides the added benefits of securing their expertise and support by assisting the company to identify acquisition candidates, which is an important part of our growth model.
Rapid Nutritions business plan is focused on three key areas:
1) Expanding our distribution in the USA, Asia, Europe and the Middle East.
2) Expand product range, technologies and intellectual property.
3) Enter into Joint Ventures and to acquire EBITDA positive acquisitions and then vend them into the listed public company to create a global conglomerate in the healthcare space for rapid and complete market penetration.
Read the rest here:
Rapidly Expanding Australian Natural Healthcare Company Goes Global
Clinical Nutrition Products Market Bounces Back From Economic Downturn
NEW YORK, NY--(Marketwire - Oct 17, 2012) - The global market for clinical nutrition products, at the manufacturers' level, should reach $28.4 billion in 2012, according to Kalorama Information. The healthcare market research publisher said that sales for clinical nutrition formulas increased 6.6% annually in the past four years due to expanding product lines in global markets, an aging population, increasing incidence of disease, a steady infant birth rate, recovering market conditions and several other factors. Growth from 2010 to 2012 showed the impact of the improving economic situation in the U.S. and other developed regions, according to the findings in The World Market for Clinical Nutrition Products, 5th Edition.
The report breaks out the market into three product segments: enteral food consumed orally such as nutritional drinks; parenteral food served to patients through feeding tubes; and infant nutrition. The infant formula segment was a major contributor to recent growth. Sales for infant formulas have increased substantially in global markets, especially in many Eastern European, Asian, and Middle Eastern regions. Additionally, an aging population and increased awareness of the relationship between health and nutrition are driving sales for all clinical nutrition products in most regions worldwide.
"The clinical nutrition market experienced a slowdown during 2009 due to the economic downturn in many developed regions," said Melissa Elder, author of the report. "Many manufacturers reported recovering sales during 2010, which continued throughout 2011 and 2012."
Growth during the forecast period is expected to be steady, continuing at the same pace in the next four years. Developments in follow-up formulas, organic formulas, and other innovative products will drive sales throughout the forecast period. The infant segment should lead growth, according to the report.
Competition in the clinical nutrition market is dominated by a handful of companies, ranging from global nutritional manufacturers to leading pharmaceutical companies. Abbott, Nestle, Fresenius Kabi, Baxter and Mead Johnson are among the key players in this market.
Kalorama Information provides detailed profiles of companies in the market, a discussion of trends, and reviews of products, as well as specific market sizes by region and product type, in its full report, The World Market for Clinical Nutrition Products, 5th Edition.
About Kalorama Information Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.
More here:
Clinical Nutrition Products Market Bounces Back From Economic Downturn
Inside Vanderbilt Lab Where Meningitis Outbreak Was Discovered
by Chris Conte
NASHVILLE, Tenn.-The microbiology lab at Vanderbilt Hospitalis the kind of place that would make any high school biology drop-out cringe, filled with vials, test tubes and enough petri dishes to fill a small warehouse.
"I'm looking for specific structures that correlate to this organism," says lab technologist Tonya Snyder while looking into a microscope.
For those that might find this place overwhelming though you can be glad it is filled with people like Tonya Snyder.
"We look through the cultures, see what might be growing," she explains.
Over the last 19 years she's been looking through microscopes here, examining cultures from patients and helping doctors make diagnosis. But whatshe saw three weeks ago on a slide from a sickened patient though was the beginning of the meningitis outbreak.
"It's tragic," she said.
It's not that Tonya had never seen this type of aspergillus fumigatus fungus before, she'd just never seen it from someone's spinal fluid.
"I don't think anybody could've seen this coming," Tonya added.
When all of this is over withhistory will record this lab as being the place where fungal meningitis first was found.
Read more from the original source:
Inside Vanderbilt Lab Where Meningitis Outbreak Was Discovered
Stem Longevity Research Links with BioProtein Technology – Renowned Partnership to Elevate Brand’s Innovative …
BioProtein Technology, a company that manufactures therapeutic proteins in the form of growth factors, has announced an alliance with Stem Longevity Research, a company partnered by Dr. Joseph Purita and CNC Reid Eckert.
(PRWEB) October 15, 2012
Stem Longevity Research has expertise in the medical applications of stem cells. Dr. Purita and Eckert will offer their high level of credibility to increase the exposure of BioProtein Technology's products on the part of physicians across the United States.
We are thrilled to welcome Dr. Purita and Reid Eckert to our team, as they are among the world's most respected stem cell researchers, said Paul Morave, National Sales Director for BioProtein Technology. With their endorsement of our products, we immediately gain a tremendous level of credibility in the eyes of doctors and medical professionals. Were very excited to begin our work with Stem Longevity Research and are looking forward to leveraging the knowledge they bring to our company.
Dr. Joseph Purita is one of the pioneers of PRP and stem cell injection research. His passion for stem cell research has helped him create the Institute of Regenerative and Molecular Orthopedics, where the standard is set for orthopedic stem cell treatments. Doctors from all over the world train in the use of PRP and stem cell treatment with Dr. Purita at the Institute.
Eckert specializes in the treatment of diseases and disorders for people of all ages. He is a certified nutritional counselor who is dedicated to bringing nutritional education and quality of life to those suffering from health challenges. Eckert also currently serves as a medical advisor for InHealth Media, a media and marketing firm that works with brands in the nutraceutical and sports nutrition industries.
BioProtein Technology offers a family of natural treatment therapies that combine the effective concepts of traditional medicine with modern technological breakthroughs. The company differentiates itself by dedicating unparalleled time and energy into a single raw material, giving its team complete top-down control of the manufacturing process.
The BioProtein Technology product line includes Velvet Antler Extract, which promotes anti-aging and naturally supports healthy cell regeneration and repair. This product balances hormones, modulates endocrine and immune systems and improves memory and cognition, among many other benefits. Other products include natural hormone and immune modulator Sub-L Tropin, topical anti-inflammatory solution Derma-T Tropin and Derma-T Tropin, an anti-aging skin care solution.
Its an honor to join the team of BioProtein Technology, a company that is doing groundbreaking work in creating top-quality alternative treatment products, said Eckert. Our goal is to significantly increase physicians awareness of this brand and the numerous benefits these products offer to individuals. Were very pleased to take part in what BioProtein Technology is doing for both doctors and their patients.
Stem Longevity Researchs work with BioProtein Technology will begin effective immediately. For more information, visit http://www.bioproteintech.com.
Read the original post:
Stem Longevity Research Links with BioProtein Technology - Renowned Partnership to Elevate Brand’s Innovative ...
Police have rape suspect’s DNA profile
Police have a DNA profile of the man who sexually assaulted a woman at North Adelaide last month, but the profile does not match any in the national database.
On September 6, a 23-year-old woman was walking home after having drinks with friends in OConnell St when she was attacked on Gover St just after midnight.
Police say the DNA profile of the offender does not match any match profiles on the National Criminal Investigation DNA Data Base, meaning the offender is unlikely to have a significant criminal history and could be a first time offender.
The suspect is described as aged in his 30s, about 175cm tall, with an olive complexion, shaved head and a calm, husky voice.
Posters depicting an image of the suspect have been distributed to businesses around North Adelaide.
We urge members of the public to take note of them and to read, have a look and to see if you recognise this person, Detective Acting Sergeant Matthew Lyon said.
Police said they have been reviewing CCTV footage and talking to local businesses as part of their ongoing enquiries.
They do not believe the attack is linked to others around North Adelaide, but have warned women to avoid walking alone at night and to stick to well-lit main roads.
Read the original here:
Police have rape suspect’s DNA profile
New DNA Test Shows Promise for Spotting Colon Cancer
By Amanda Gardner HealthDay Reporter
TUESDAY, Oct. 16 (HealthDay News) -- Scientists have developed a new DNA test for colorectal cancer and for cancer precursors that seems to be not only accurate, but also noninvasive.
If approved by the U.S. Food and Drug Administration, experts say, the test could be a welcome alternative to colonoscopies, which require a lengthy and uncomfortable preparation.
"The study is interesting and may hold some promise in the future," said Dr. David Beck, chairman of the department of colon and rectal surgery at Ochsner Medical Center in New Orleans. "More testing needs to be done to confirm the findings, and we need to know how available the test will be and what it will cost."
"Currently, it is estimated that almost 50 percent of Americans have not been screened [by any method] for colorectal cancer," added Beck, who was not involved with the study. "Most tests are better than nothing. If further study confirms the usefulness of this test, it would be a significant help."
The researchers began with stool samples from more than 1,000 people who were undergoing colonoscopies for screening and who had just had a colonoscopy that identified a malignancy or pre-malignancy.
In previous studies, the researchers had identified 11 biomarkers that, when combined, could indicate the presence of cancerous or precancerous lesions.
The test has three components, said study author Graham Lidgard, senior vice president of research and development and chief science officer at Exact Sciences in Madison, Wis., which developed the test and funded the research.
The first identifies methylation in two genes. Methylation is a process that can turn off tumor suppressor genes that would normally help curb the proliferation of cancer cells. Abnormal methylation can be found in both colorectal cancers and pre-cancers.
The second component searches for DNA mutations in the K-ras gene. Mutations in this gene can spur tumor growth, and these mutations can be identified both in cancers and in pre-cancers.
Read this article:
New DNA Test Shows Promise for Spotting Colon Cancer
Fake 'Gum Survey' DNA Solves Case
A DNA sample from a phony "chewing gum survey" led to the arrest of a man who has been charged with killing a 70-year-old woman in 1976, making this the oldest cold case to ever be cracked in Maine.
Gary Sanford Raub, 63, was arrested on Monday in Seattle and charged with murdering 70-year-old Blanche Kimball in Augusta, Maine.
Kimball was found stabbed to death inside her State Street home on June 12, 1976 after neighbors called police to say they had not seen her for several days. The killer eluded investigators and the case turned cold, but authorities kept at it over the decades.
"In Maine, State Police assign the open homicide cases to a detective. There's always a detective assigned to these cases, which are constantly reviewed, as time permits," Maine State Police spokesman Steve McCausland told ABCNews.com.
Recent DNA work by the State Police Crime Lab on evidence from the crime led them to Raub, authorities said.
"It was last summer that we got some very concrete DNA work on some of the evidence that was seized and made a comparison that brought us to this point," McCausland said. "It was DNA that cracked this."
Raub was tracked to Seattle, where he was living as a homeless transient and police knew him from his lengthy criminal record. Authorities discovered that Raub knew Kimball and had at one time lived at her home.
Augusta investigators coordinated with authorities in Seattle and used a fake "gum chewing survey" to get a new DNA sample from Raub.
"I don't know the exact details, but we obviously needed some up-to-date DNA from him and some bubble gum was the key to getting that," McCausland said.
Three decades later, investigators remained committed to finding justice for Kimball.
Continued here:
Fake 'Gum Survey' DNA Solves Case
Genome Hunters Go after Martian DNA
Two high-profile entrepreneurs say they want to put a DNA sequencing machine on the surface of Mars in a bid to prove the existence of extraterrestrial life.
In what could become a race for the first extraterrestrial genome, researcher J. Craig Venter said Tuesday that his Maryland academic institute and company, Sythentic Genomics, would develop a machine capable of sequencing and beaming back DNA data from Mars.
Separately, Jonathan Rothberg, founder of Ion Torrent, a DNA sequencing company, is collaborating on an effort to adapt his company's "Personal Genome Machine" for Martian conditions.
"We want to make sure an Ion Torrent goes to Mars," Rothberg told Technology Review.
Although neither team yet has a berth on Mars rocket, their plans reflect the belief that the simplest way to prove there is life on Mars is to send a DNA sequencing machine to the planet.
"There will be DNA life forms there," Venter predicted Tuesday in New York, where he was speaking at the Wired Health Conference.
Venter said researchers working with him have already begun tests at a Mars-like test site in the Mojave Desert. Their goal, he said, is to demonstrate a machine capable of autonomously isolating microbes from soil, sequencing their DNA, and then transmitting the information to a remote computer, as would be required on an unmanned Mars mission. (Hear his comments in this video, starting at 00:11:01). Heather Kowalski, a spokeswoman for Venter, confirmed the existence of the project, but also said the prototype system was "not yet 100 percent robotic."
Meanwhile, Rothberg's Personal Genome Machine is being adapted for Martian conditions as part of a NASA-funded project at Harvard and MIT called SET-G, or "the search for extra-terrestrial genomes."
Christopher Carr, an MIT research scientist involved in the effort, says his lab is working to shrink Ion Torrent's machine from 30 kilograms down to just 3 kilograms so that it can fit on a NASA rover. Other tests, already conducted, have determined how well the device can withstand the heavy radiation it would encounter on the way to Mars.
NASA, whose Curiosity rover landed on Mars in August, won't send another rover mission to the planet before at least 2018 (see "The Mars Rover Curiosity Marks a Technological Triumph"), and there's no guarantee a DNA sequencing device would go aboard. "The hard thing about getting to Mars is hitting the NASA specifications," says George Church, a Harvard University researcher and a senior member of the SET-G team. "[Venter] isn't ahead of anyone else."
Originally posted here:
Genome Hunters Go after Martian DNA
This McMaster scientist has a taste for cage fighting
The biochemistry research that should earn him a PhD by next summer involves categorizing the structure of a nonpathogenic protein from an obscure bacteria that apparently exist at a near-atomic level.
I think thats what its about, anyway. Youd need a couple of masters degrees to do more than simply nod along politely as he talks about bioremediation and terraforming and something called Deinococcus Radiodurans that can apparently recover from extreme damage, which makes it a huge deal for doctors and even NASA, which has taken some into space for study. Or something like that.
Smart? Uh, yeah. Seiji Sugiman-Marangos is off the charts.
Which makes you wonder why a McMaster student with a brain like this will walk into a cage on Friday night and risk it by fighting another man in a mixed martial arts bout. After all, its kind of a given that being kicked and punched and elbowed and kneed in the head isnt ideal for brain cells.
For me, its just about competing, he says.
Make no mistake, the 27-year-old featherweight whose name is pronounced Say-jee Soogie-man Marangoes is acutely aware of the danger. He gets how valuable the cargo inside his skull is for his future. He understands the risks. But he also feels the lure of the game.
Growing up, he says he wasnt good at any sports. But as soon as he tried karate as a teenager, he found his sweet spot. He was good at it right away and loved it. That led to taekwondo and other martial arts before finding his way into a jiu-jitsu gym.
His laughs talking about his first time sparring when a teenage girl and then a very small boy manhandled him. But he worked at and soon became pretty proficient.
Watching a couple of professional fighters work out, he started thinking he should give the game a try for real. Mostly because he says it seemed like a waste of time to spend so much time training for nothing.
But the thought of taking blows to the head is never far away. He can take a punch. He has. Truth is, hes fearless and maybe too tough for his own good.
Go here to see the original:
This McMaster scientist has a taste for cage fighting
Harvard Ophthalmologist Dr. Ula Jurkunas Introduces Stem Cell Transplant for Eyes
Grants Pass, OR (PRWEB) October 16, 2012
Harvard Ophthalmologist and Corneal Stem Cell Researcher Ula Jurkunas, MD, has announced an important new stem cell transplant procedure for the eyes.
Speaking on the Sharon Kleyne Hour Power of Water radio show, Dr. Jurkunas, predicted that the procedure will offer a significant benefit to patients with certain corneal diseases, and corneal injuries such as chemical and thermal burns (The cornea is the eyes clear portion).
Stem cell research has been in the news because the 2012 Nobel Prize for Medicine was awarded for stem cell research.
Dr. Jurkunas explained to host Sharon Kleyne that the human eye produces its own adult (non-embryonic) stem cells. These are found between the limbus (where the clear cornea meets the white of the eye) and the conjunctiva (the red meaty tissue in the eyes inner corner). Their function is to replenish corneal cells to keep the cornea clear and healthy.
Production of corneal stem cells, according to Dr. Jurkunas, can become impaired due to a disease entity such as an infection, severe allergy, severe dry eye, immunological disorder or chronic inflammation; or due to injury such as a chemical or thermal burn. These traumas can cause the cornea to become cloudy and ulcerated. Prior to the present corneal stem cell research, there had been no reliable, non-invasive treatment for these conditions.
Corneal stem cell transplantation, Dr. Jurkunas explains, has the advantage of utilizing the patients own tissue as donor cells. Stem cells may be taken either from healthy tissue elsewhere in the diseased eye, from the patients other eye, or from the patients inner cheek (which has many similarities to eye tissue and also produces adult stem cells). Donor stem cells are then isolated and grown in culture. The final step is to transfer them to the affected cornea using a stem cell bandage.
The procedure, says Dr. Jurkunas, has resulted in dramatic corneal clearing and sight restoration. Although research is ongoing and the procedure remains experimental, corneal stem cell therapy is available in clinical trials. Widespread applications of the procedure, including routine testing for corneal stem cell deficiency, are anticipated. Stem cell therapy, according to Dr. Jurkunas, could eventually be used for macular degeneration, glaucoma and other eye diseases.
Dr. Jurkunas stressed the importance of water and hydration in maintaining a healthy tear film and cornea. The tear film covering the cornea is 99% water and is essential to the light refraction that enables vision. Dry eye and related eye infections, according to Dr. Jurkunas, can damage both the cornea and adjacent stem cell producing tissues that enable the cornea to repair itself. Water in the tear film stimulates the healthy production of stem cells. Water is also critical to keeping stem cells viable during transplantation.
Mrs. Kleyne and Dr. Jurkunas agree that non-invasive therapies using the bodys own tissues, such as corneal stem cell transplantation, could eventually prove indispensable in combating the worldwide health effects of global drying and dehydration.
View post:
Harvard Ophthalmologist Dr. Ula Jurkunas Introduces Stem Cell Transplant for Eyes






